Drug profile · INN
garadacimab
ANDEMBRY
garadacimab (ANDEMBRY) is an FDA-listed pharmaceutical active ingredient.
EMA: approved PMDA: approved Blood and blood forming organs (B06) B06AC07
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — garadacimab
- Class
- Blood and blood forming organs (B06)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
garadacimab (ANDEMBRY) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN garadacimab
Brand ANDEMBRY
Therapeutic class Blood and blood forming organs (B06)
ATC code B06AC07
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is garadacimab?
garadacimab (ANDEMBRY) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for garadacimab?
ANDEMBRY is a marketed brand name for garadacimab. Check FDA Drugs@FDA for the current US label holder and prescribing information.